Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes

Journal of Clinical Investigation

Volumn 96, Issue 2, 1995, Pages 1093-1099

  Thaik, Cynthia M ^a   Calderone, Angelino ^a   Takahashi, Nobuyuki ^a   Colucci, Wilson S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

atrial natriuretic factor; calcium release channel; cytokines; sarcoplasmic reticulum calcium2+ ATPase; voltage dependent calcium channel; myosin heavy chain

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL; CYTOKINE; INTERLEUKIN 1BETA; MYOSIN; NITRIC OXIDE SYNTHASE; RYANODINE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DNA SYNTHESIS; GENE EXPRESSION REGULATION; GROWTH REGULATION; HEART MUSCLE CELL; INFLAMMATION; MYOCARDITIS; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; RAT; REGULATOR GENE; REGULATORY MECHANISM; SARCOPLASMIC RETICULUM;

EID: 0028982834     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118095     Document Type: Article

References (44)

1. Zerbe, T. R. 1989. Contrast of mediators: identification of cells and cytokines in human heart tissue with acute rejection and myocarditis. Transplant. Proc. 21:443-444.
2. Mayani, H., W. Dragowska, and P. M. Lansdorp. 1993. Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells. Blood. 81:3252-3258.
3. Libby, P., S. J. C. Warner, and G. B. Friedman. 1988. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J. Clin. Invest. 81:487-498.
4. Cozzolino, F., M. Torcia, D. Aldinucci, M. Ziehe, F. Almerigogna, D. Bani, and D. M. Stern. 1990. Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc. Natl. Acad. Sci. USA. 87:6487-6491.
5. Macchia, G., C. T. Baldari, A. Massone, and J. L. Telford. 1990. A role for protein kinase C activity in interleukin-1 (IL-1) induction of IL-2 gene expression but not in IL-1 signal transduction. Mol. Cell. Biol. 10:2713-2717.
6. Marczin, N., A. Papapetropoulos, and J. D. Catravas. 1993. Tyrosine kinase inhibitors suppress endotoxin- and IL-1 β-induced NO synthesis in aortic smooth muscle cells. Am. J. Physiol. 265:H1014-H1018.
7. Bilsen, M. V., and K. R. Chien. 1993. Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc. Res. 27:1140-1149.
8. Balligand, J.-L., D. Ungureanu, R. A. Kelly, L. Kobzjk, D. Pimentai, T. Michel, and T. W. Smith. 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91:2314-2319.
9. Roberts, A. B., Y. Vodovotz, N. S. Roche, M. B. Sporn, and C. F. Nathan. 1992. Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin-1β on the beating rate of cultured cardiac myocytes. Mol. Endocrinol. 6:1921-1930.
10. Morishita, R., G. H. Gibbons, R. E. Pratt, N. Tomita, Y. Kaneda, T. Ogihara, and V. J. Dzau. 1994. Autocrine and paracrine effects of ANP gene transfer on vascular smooth muscle and endothelial cell growth. J. Clin. Invest. 94:824-829.
11. Lane, J. R., D. A. Neumann, A. Lafond-Walker, A. Herskowitz, and N. R. Rose. 1992. Role of IL-1 and tumor necrosis factor in Coxsackie virus-induced autoimmune myocarditis. J. Immunol. 151:1682-1690.
12. Han, R. O., E. R. Phillip, K. L. Baughman, and A. M. Feldman. 1991. Detection of interleukin and interleukin-receptor mRNA in human heart by polymerase chain reaction. Biochem. Biophys. Res. Commun. 181:520-523.
13. Ulich, T. R., K. Z. Guo, B. Irwin, D. G. Remick, and G. N. Davatelis. 1990. Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression. Am. J. Pathol. 137:1173-1185.
14. Kasten, F. J. 1973. In Tissue Culture Methods and Applications. P. F. Kruse, Jr. and M. K. Patterson, Jr., editors. Academic Press. New York. 72-86.
15. 1 expression in rat ventricular myocytes. J. Clin. Invest. 94:1470-1476.
16. 2+ independent NOS in the myocardium. Br. J. Pharmacol. 105:575-580.
17. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of micrograms quantities of protein utilizing the principles of protein dye binding. Anal. Biochem. 72:248-254.
18. Steiner, A. L., C. W. Parker, and D. M. Kipnis. 1972. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J. Biol. Chem. 247:1106-1113.
19. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Annal. Biochem. 162:156-159.
20. 1B-adrenergic receptor mRNA in vascular smooth muscle cells. J. Biol. Chem. 269:1705-1710.
21. Gustafson, T. A., B. E. Markham, and E. Morkin. 1985. Analysis of thyroid hormone effects on myosin heavy chain gene expression in cardiac and soleus muscles using a novel dot-blot mRNA assay. Biochem. Biophys. Res. Commun. 130:1161-1167.
22. 1Adrenergic stimulation of rat myocardial cells increases protein synthesis. Am. J. Physiol. 251:H1076-H1084.
23. 1 receptor subtype. Circ. Res. 73:413-423.
24. Ito, H., Y. Hirata, M. Hiroe, M. Tsujino, S. Adachi, T. Takamoto, M. Nitta, K. Taniguchi, and F. Marumo. 1991. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ. Res. 69:209-215.
25. Parker, T. G., S. E. Packer, and M. D. Schneider. 1990. Peptide growth factors can provoke fetal contractile protein gene expression in rat cardiac myocytes. J. Clin. Invest. 85:507-514.
26. Izumo, S., B. Nadal-Ginard, and V. Mahdavi. 1988. Proto-oncogene induction and reprogramming of the cardiac gene expression produced by pressure overload. Proc. Natl. Acad. Sci. USA. 85:339-343.
27. Dinarello, C. A. 1984. Interleukin-1. Rev. Infect. Dis. (Suppl. to J. Infect. Dis.) 6:51-95.
28. Parker, T. G., K. L. Chow, R. J. Schwartz, and M. D. Schneider. 1990. Different regulation of skeletal apha-actin transcription in cardiac muscle by two fibroblast growth factors. Proc. Natl. Acad. Sci. USA. 87:7066-7070.
29. Morgan, J. P. 1991. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N. Engl. J. Med. 325:625-632.
30. 2+-ATPasc and function of sarcoplasmic reticulum during cardiac hypertrophy. Am. J. Physiol. 261:23-26.
31. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J. Clin. Invest. 85:305-309.
32. Arai, M., N. R. Alpen, D. H. MacLennan, P. Barton, and M. Periasamy. 1993. Alterations in sarcoplasmic reticulum gene expressionin human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ. Res. 72:463-469.
33. Feldman, A. M., E. O. Weinberg, P. E. Ray, and B. H. Lorell. 1993. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ. Res. 73:184-192.
34. Movsesian, M. A., K. Mohsen, K. Green, and L. R. Jones. 1994. Calcium-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 90:653-657.
35. Brillantes, A.-M., P. Allen, T. Takahashi, S. Izumo, and A. R. Marks. 1992. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ. Res. 71:18-26.
36. 2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J. Clin. Invest. 90:927-935.
37. Yokoyama, T., L. Vaca, R. D. Rossen, W. Durante, P. Hazarika, and D. L. Mann. 1993. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J. Clin. Invest. 92:2303-2312.
38. Roberts, A. B., N. S. Roche, T. S. Winokur, J. K. Burmester, and M. B. Sporn. 1992. Role of transforming growth factor-β in maintenance of function of cultured neonatal cardiac myocytes. J. Clin. Invest. 90:2056-2062.
39. Thaik, C. M., K. Singh, N. Takahashi, A. Calderone, and W. S. Colucci. 1994. The role of mitogen activated protein kinase and second messenger system in interleukin-1β-induced cardiac myocyte growth. Circulation. 90:1-194.
40. Hosenpud, J. D., S. M. Campbell, and G. Pan. 1990. Indirect inhibition of myocyte RNA and protein synthesis by interleukin-1. J. Mol. Cell. Cardiol. 22:213-225.
41. Long, C. S., C. J. Henrich, and P. C. Simpson. 1991. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Regul. 2:1081-1095.
42. Mann, D. L., and J. B. Young. 1994. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest. 105:897-904.
43. Dec, G. W., I. F. Palacios, J. T. Fallon, H. T. Aretz, J. Mills, D. C.-S. Lee, and R. A. Johnson. 1985. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates and clinical outcome. N. Engl. J. Med. 312:885-890.
44. Jones, S. R., A. Herskowitz, G. M. Hutchins, and K. L. Baughman. 1991. Effects of Immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function. Am. J. Cardiol. 68:370-376.